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with antimicrobial protein granules and 
enzymes.[5] NETs have been observed 
to be lethal to a number of bacteria,[6] 
fungi,[7] viruses,[8] and parasites,[9] yet 
some pathogenic bacteria can evade 
NET-induced killing.[10,11] Accumulation 
of excessive NETs in vivo is also associ-
ated with pathology of bacterial biofilm, 
autoimmune disease, and even cancer.[12] 
These complex and sometimes contradic-
tory observations highlight the need to 
investigate NET-related physiological inter-
actions with simpler but defined NET-like 
biomaterials.
Isolation of NETs from neutrophils 
requires repeated centrifugation and 
washing steps,[13] which often causes unpre-
dictable loss of proteins. Moreover, NETs 
can be triggered via chemical stimulus,[14] 
virulence factors,[15] and bacteria[16] under 
different pathways, yielding 33 common 
proteins and as much as 50 variable 
proteins.[12] While the existing antibodies 
and inhibitors are employed to block and 
characterize the function of specific NET components, their high 
complexity imposes limitations.[17] Here, we take a bottom-up 
approach of synthesizing NET-like materials with defined compo-
sition, termed “microwebs,” through sonochemical complexation 
of lambda phage DNA and histone in aqueous solutions. Lambda 
phage DNA can spontaneously polymerize into networks in the 
presence of histone,[18] which facilitates formation of web-like 
structure. Escherichia coli UTI89 was used as a model pathogen 
Neutrophil extracellular traps (NETs) are decondensed chromatin networks 
released by neutrophils that can trap and kill pathogens but can also 
paradoxically promote biofilms. The mechanism of NET functions remains 
ambiguous, at least in part, due to their complex and variable compositions. 
To unravel the antimicrobial performance of NETs, a minimalistic NET-like 
synthetic structure, termed “microwebs,” is produced by the sonochemical 
complexation of DNA and histone. The prepared microwebs have structural 
similarity to NETs at the nanometer to micrometer dimensions but with well-
defined molecular compositions. Microwebs prepared with different DNA 
to histone ratios show that microwebs trap pathogenic Escherichia coli in a 
manner similar to NETs when the zeta potential of the microwebs is positive. 
The DNA nanofiber networks and the bactericidal histone constituting 
the microwebs inhibit the growth of E. coli. Moreover, microwebs work 
synergistically with colistin sulfate, a common and a last-resort antibiotic, 
by targeting the cell envelope of pathogenic bacteria. The synthesis of 
microwebs enables mechanistic studies not possible with NETs, and it opens 
new possibilities for constructing biomimetic bacterial microenvironments to 
better understand and predict physiological pathogen responses.
Biomimetics
Nature uses a variety of extracellular nanofibers, such as 
cobwebs,[1] amyloid plaques,[2] and fibrin clots[3] to capture 
invading microbes. As part of human innate immunity, 
neutrophils squirt decondensed chromatin networks to capture 
and disarm bacteria and fungi—a host defense process known 
as “NETosis”[4] (Figure 1a). Such endogenous networks, 
named neutrophil extracellular traps (NETs; Figure 1b), are 
composed of meshes of DNA strands and histone, decorated 
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because NETs were essential for the clearance of E. coli; moreover, 
the first clinical isolate of colistin-resistant bacteria harboring the 
mcr-1 gene in the US was E. coli from a urinary tract infection 
(UTI).[19] We evaluated the antimicrobial performance of NETs 
versus microwebs of different composition in comparative 
studies. We show how the microwebs trap E. coli and inhibit their 
growth as NETs do. In addition, we demonstrate that the micro-
webs can work synergistically with colistin sulfate to kill E. coli. 
Compared to isolation of NETs from neutrophils, our synthetic 
approach allows fast and larger-scale preparation of NET-like 
structures with well-defined compositions. This approach there-
fore provides a platform to study mechanisms of NET-bacteria 
interactions with less confounding factors to promote under-
standing of NET-related human diseases.
Inspired from decondensed chromatin structure of NETs, 
our synthetic “microwebs” were prepared by a sonicated 
mixture solution of DNA and histone (see the Experimental 
Section). Methylated lambda phage DNA was selected to 
formulate microwebs because its DNA length (48502 bp) is 
suitable for forming uniform and dispersible networks by soni-
cation. At physiological DNA concentrations (≈100 µg mL−1), 
shorter DNA only forms microparticles with histone in Hank’s 
balanced salt solution (HBSS), while longer DNA results in 
large clumps that cannot be easily dispersed. After applying 
ultrasonication to the phage DNA/histone mixture, we obtained 
disassembled DNA-rich bundles decorated with histone-rich 
granules (Figure 1c,d). The resultant structure showed quali-
tative ultrastructural similarity to NETs collected from neutro-
phils. The thickness of the DNA bundles varied from 20 to 
100 nm, in agreement with ultrafine nanostructures observed in 
NETs.[20] The formation of the microwebs is driven by the elec-
trostatic complexation of DNA (zeta potential, ζ = −22 mV) with 
Adv. Mater. 2019, 31, 1807436
Figure 1. Synthesis and characterization of NET-like microwebs. a) Scheme and b) scanning electron microscopy illustrating NETs. c) Scheme and d) 
SEM illustrating microwebs. Scale bars = 1 µm. e) Zeta potentials and f) size distribution (DLS measurement) of microwebs. Size distribution of sonicated 
NETs is shown by the red curve. g) DNase-induced degradation of microwebs in HBSS. Microwebs were stained by SYTOX (Ex/Em = 488/523 nm).
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histone (ζ = +11.3 mV). When the histone weight fraction in the 
microwebs, ωhis, was increased from 15 to 60 wt%, the DNA 
fibers were gradually covered by a coating of histone granules 
(Figure S1, Supporting Information), resulting in elevated zeta 
potentials (Figure 1e). When the histone fraction ωhis is above 
an upper limit of 60 wt%, the DNA-rich bundles were fully 
occupied by histone granules and therefore further attachment 
of histone to DNA was inhibited by electrostatic repulsion.
The maximum protein-loading capacity of the microwebs, 
ωhis,max = 60 wt%, is consistent with the reported fraction of 
all proteins in NETs (including histone, neutrophil elastase, 
cathepsin G, and other proteins) measured by mass spec-
trometry.[13] Microwebs with ωhis = 50 wt% acquire ultrafine 
structures like NETs. Dynamic light scattering (DLS) 
measurement of the sonicated microwebs suggests that the 
hydrodynamic diameter of the DNA bundles is comparable to 
that in NETs (Figure 1f). Due to the presence of histone, DNA 
colloids slowly aggregate and their hydrodynamic diameters 
increase over the time of aging (Figure S1, Supporting Infor-
mation). Similar to NETs, the microwebs can be degraded 
by DNase I (Figure 1g).[6,21] The degradation rate of micro-
webs increased with the DNase concentration, as shown by 
the fluorescence quenching of the SYTOX-labeled microwebs 
after degradation of DNA (Figure 1g; Figure S2, Supporting 
Information).
Since the primary function of NETs is to trap bacteria,[6] 
we first tested the ability of microwebs to entrap the Gram-
negative urinary pathogen, E. coli UTI89. Microwebs with 
different histone weight fractions, ωhis = 25%, 40%, 50%, and 
57%, were employed as matrices to trap bacteria. To enable 
sufficient contact between E. coli and microwebs, we sequen-
tially centrifuged the microwebs and bacteria so that the plank-
tonic E. coli cells were forced onto the precipitated microwebs 
at time zero, t = 0 h. However, the temporarily attached E. coli 
can subsequently detach from the microwebs through bacterial 
movement. After 1 h of incubation, a near-steady-state bacterial 
entrapment was achieved, and the nonattached bacteria were 
removed by pipette washing. We observed that a higher density 
of E. coli cells was trapped on the positively charged micro-
webs than on the negatively charged and neutral microwebs, 
as shown by scanning electron microscopy (SEM) observation 
in Figure 2a–c. To quantify the number of entrapped bacteria, 
we prestained E. coli and then monitored the bacterial motion 
on microwebs for 1 h in HBSS. The entrapped E. coli cells 
were defined as those immobilized on microwebs without any 
observable motion, while the nonentrapped E. coli cells were 
Adv. Mater. 2019, 31, 1807436
Figure 2. Entrapment of E. coli on microwebs. SEM images showing E. coli trapped on microwebs with a) ζ = −8 mV, b) ζ = 0 mV, and c) ζ = +6.5 mV. 
Scale bars = 10 µm. d) The percentage of trapped E. coli on microwebs as a function of incubation time. e) The number of planktonic E. coli escaped 
from microwebs were counted by plating and colony forming unit enumeration. The percentage of planktonic E. coli is calculated from the ratio of 
E. coli in supernatants relative to that in NET-free control group. **P < 0.01.
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observed to self-rotate or swim to a different location under the 
microscope. After manually counting the number of motile 
and nonmotile E. coli, we found that 82% ± 4% (ζ = +5 mV, 
ωhis = 50%) and 93% ± 3% (ζ = +8 mV, ωhis = 57%) E. coli 
cells were trapped on microwebs with positive zeta poten-
tials, in good agreement with the trapping observed on NETs 
(Figure 2d,e).[22] In contrast, less than 10% of E. coli cells were 
attached to the negatively charged (−9 mV) and near-neutral 
(−1 to +1 mV) microwebs. As the time of incubation increases, 
some E. coli cells initially attached to these microwebs were 
seen to detach. The membrane potential of these detached 
bacteria was elevated (ζ ≈ 0 mV) compared to the untreated 
E. coli (ζ = −12 mV). This is probably caused by either adap-
tion of bacteria to microwebs or adsorption of histone to the 
bacterial cell wall. The detached E. coli cells in supernatant 
was further enumerated by serial dilution, plating, and colony 
counting. The results confirmed that positively charged 
microwebs efficiently inhibited the dispersion of E. coli as 
compared to negatively charged microwebs (Figure 2e). The 
charge-dependent bacterial trapping can be explained by an 
energy barrier set by the electrostatic interaction between the 
bacterial cell wall (e.g., lipopolysaccharide) and microwebs. 
A higher fraction of cationic histone (ωhis > 40%) in microwebs 
and therefore a higher electrostatic force enhanced the bacteria 
trapping efficiency.
To test if microwebs kill the trapped E. coli, we placed 
microwebs on top of E. coli cells through centrifugation and 
incubated the trapped E. coli for 1 h in HBSS. Subsequently, we 
removed the microwebs from E. coli cells by repeated washing 
and stained the remaining bacteria with the LIVE/DEAD 
BacLight bacterial viability kit. Using confocal laser scanning 
microscopy (CLSM), we found that most E. coli cells remained 
alive in microwebs and a small fraction were dead (red, 
Figure 3b). SEM observation reveals that live bacteria had intact 
capsules similar to those cultured in tryptic soy broth (TSB) 
(Figure 3f). Some of the microweb-entrapped E. coli cells were 
seen to shrink similar to those trapped on NETs (Figure 3g,h). 
The successful permeation of propidium iodide into these cells 
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Figure 3. Viability assessment of E. coli cultured with microwebs. Fluorescence microscopy images of E. coli in a) tryptic soy broth, b) 100 µg mL−1 
microwebs (ωhis = 50%), c) 100 µg mL−1 NETs, d) 50 µg mL−1 DNA solution, and e) 50 µg mL−1 histone solution (live cells: green; dead cells: red). Scale 
bars = 10 µm. The corresponding SEM images of E. coli cells cultured in indicated solutions are shown in (f) to (j). Scale bars = 1 µm. k) Microwebs 
reduce colony forming units of E. coli in HBSS. 105 E. coli cells were incubated in 100 µL microwebs (50 µg mL−1 DNA, ωhis = 50%), NETs (contains 
50 µg mL−1 DNA, triggered by phorbol 12-myristate 13-acetate), 50 µg mL−1 DNA, and 50 µg mL−1 histone, respectively, for 1 h before transferred to 
agar plates. **P < 0.01; ***P < 0.001. Growth curves of E. coli in a mixture of 100 µL microweb suspension and 100 µL TSB plus 1% glucose.
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suggests loss of membrane integrity (Figure 3b). To determine 
which component in microwebs caused structural damage to 
E. coli cell wall, we separately cultured E. coli in the isolated 
DNA (Figure 3d,i) or histone solutions (Figure 3e,j). Within 
the range of physiologically relevant DNA concentrations 
(25–100 µg mL−1), the viability of E. coli cells cultured in the 
DNA solution remained. In contrast, an increased cell death 
rate was observed after E. coli cells were cultured in a series 
of histone solutions with increasing protein concentration 
(25–100 µg mL−1). SEM observation of these dead cells showed 
damaged capsules with nanosized pores. Previous studies have 
shown that histone H2B penetrates through E. coli membrane, 
and histone H3 and H4 can destruct bacterial cell wall.[23] To 
test if these membrane pores we observed are structural defects 
caused by dehydration of cells before SEM observation, we also 
used fluorescein isothiocyanate (FITC) to label histone and 
identify their bactericidal effect under CLSM. Our observation 
showed that FITC–histone alone can efficiently cause lysis of 
bacteria E. coli (Figure S3, Supporting Information). However, 
once complexed with DNA to form microwebs, the FITC–
histones no longer break the cell membrane. Instead, these 
FITC–histones were absorbed on the E. coli cell wall.
To further quantify the antimicrobial potency of microwebs, 
we cultured E. coli in suspensions with microwebs (in HBSS) 
before they were diluted and transferred to agar plates for 
colony forming unit (CFU) enumeration (Figure 3k). The 
presence of microwebs (100 µg mL−1) reduces CFU counts of 
E. coli (106 mL−1) by 41% ± 8%, in agreement with the reduced 
CFU counts in the NETs group (32% ± 7%). By separately using 
DNA and histone as additives to culture medium, we confirmed 
that histone, rather than DNA, was the direct bactericidal 
component against E. coli. When E. coli were cultured in a 
nutrient-rich medium of 50 vol% TSB and 50 vol% HBSS 
containing microwebs (Figure 3l), we did not observe an imme-
diate decline in the bacterial proliferation rate within the first 
2 h, perhaps due to the diffusion-limited penetration of histone 
through the E. coli cell wall. However, microwebs reduced the 
overall E. coli cell number in the stationary phase (t = 4–6 h), 
which is attributed to the trapping and mild killing effects of 
the microwebs. After microwebs were dismantled by DNase I, 
the remaining structures no longer inhibit bacterial growth 
in the stationary phase (Figure S4, Supporting Information). 
Our observation suggests that the network of DNA nanofibers 
also contributes to the antimicrobial potency of the microwebs, 
in agreement with previous reports on DNase-induced loss of 
antimicrobial potency of NETs.[6,10,11] The supernatant resulting 
from preparation of microwebs does not significantly change 
the growth curve of E. coli (Figure S4, Supporting Information), 
suggesting that free histone remaining in the supernatant 
is trivial. The antimicrobial mechanism of action of the 
microwebs, therefore, mainly relies on their direct contact with 
bacteria. Some of the entrapped E. coli cells exhibited phenotype 
changes, such as filamentous growth (Figure S5, Supporting 
Information). Filamentation is generally considered a protective 
strategy for bacteria to evade stressed conditions, such as anti-
biotic treatment and phagocytosis of macrophages.[24] In view 
of the responses of E. coli to microwebs, we propose that micro-
webs are bacteriostatic networks with functions of trapping and 
moderate inhibition of E. coli proliferation.
As a structural and chemical analogue of NETs, microwebs 
can be used for convenient screening of antibiotics which may 
function cooperatively with physiologically-produced NETs. To 
test this hypothesis, we measured the tolerance of E. coli to dif-
ferent antibiotics with and without microwebs (ωhis = 50%). 
Four clinically potent antibiotics for urinary tract infection, 
including amoxicillin, colistin sulfate, nitrofurantoin, and tri-
methoprim were tested. In HBSS, the antimicrobial potency of 
amoxicillin and colistin sulfate was significantly enhanced in 
the presence of microwebs (100 µg mL−1), as shown by quan-
titative culture in Figure 4a,b. This antibacterial enhancement 
was also identified by determining the minimum inhibitory 
concentration (MIC) by standard broth microdilution for each 
antibiotic with and without microwebs. Without addition of 
microwebs, the MICs of colistin sulfate and amoxicillin are 3 
and 12 µg mL−1, respectively. With addition of microwebs, the 
MICs for colistin sulfate and amoxicillin were reduced to 0.75 
and 6 µg mL−1, respectively. Similar antimicrobial enhance-
ment was also observed when enumerating the CFU counts 
of colistin-resistant E. coli strain IHD86_4 (+mcr-1) in HBSS 
(Figure S6, Supporting Information). Colistin is a last resort 
antibiotic used against multidrug resistant E. coli that has a 
side effect of frequently causing acute kidney injury.[25] Dosing 
at a level that is bactericidal while minimizing risk of kidney 
injury is an important clinical challenge. Our results suggest an 
interesting possibility that endogenous NETs may assist colistin 
in fighting bacteria in vivo, allowing for the use of lower doses 
than may seem necessary with conventional in vitro antibiotic 
susceptibility tests performed in the absence of NETs. Interest-
ingly, colistin has been reported to sensitize human neutrophil-
induced killing of resistant E. coli in vivo.[26]
From the growth curve of E. coli with colistin treatment, we 
observed that the slope of the exponential phase, which was 
not affected by colistin treatment alone (Figure 4c), decreased 
with increasing concentrations of colistin in the presence of 
microwebs (Figure 4d). As colistin sulfate disrupts the bacterial 
membrane,[27] the decreased slope of the exponential growth 
phase may be explained by the enhanced permeability of the 
bacterial cell wall induced by histone. In comparison, the slopes 
of the exponential phase for the amoxicillin-treated E. coli were 
less affected by amoxicillin concentration, regardless of the 
presence of microwebs (Figure 4e,f). Amoxicillin can inhibit 
the synthesis of cell wall but does not disrupt the cell mem-
brane; therefore, with the unchanged membrane permeability 
to histone, the slope of exponential phase does not change even 
with increased concentration of amoxicillin (Figure 4f) when it 
is below the MIC. Additionally, microwebs did not change the 
MIC for nitrofurantoin and trimethoprim (see Figure S7 in the 
Supporting Information), as nitrofurantoin targeted ribosomal 
proteins and trimethoprim inhibited DNA synthesis.[28] Our 
results suggest that microwebs can collaboratively work with 
antibiotics that targets the bacterial cell envelope.
In summary, we synthesized NET-like microwebs through 
sonochemical complexation of DNA and histone. To the best 
of our knowledge, this is the first report demonstrating that 
manipulation on the morphology and composition of DNA–
histone complex can achieve antimicrobial functions similar 
to endogenous NETs. By varying the ratio of DNA to histone, 
we correlated the bacteria trapping and antimicrobial properties 
Adv. Mater. 2019, 31, 1807436
© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1807436 (6 of 8)
www.advmat.dewww.advancedsciencenews.com
of the microwebs with regards to their DNA to histone ratio. 
This synthetic approach provides a flexible platform to quanti-
tatively study the physiology role of different NET components. 
The compositionally minimalistic microwebs efficiently trap 
E. coli through electrostatic forces to an extent similar to NETs. 
DNase-mediated degradation experiments demonstrate that the 
network of DNA nanofibers also contribute to the inhibition 
of bacterial proliferation. E. coli exhibited filamentous growth, 
a well-known adaptive response, when exposed to both micro-
webs and NETs. Interestingly, microwebs work collaboratively 
with the last-resort antibiotic colistin and target bacterial cell-
envelope, including colistin-resistant E. coli (IHD86_4 mcr-1). 
These results show that microwebs are useful for studying bac-
teria-NET interactions and for screening of antimicrobials that 
works collaboratively with physiologically-produced NETs.[29] 
Since DNA-based NETs are also associated with pathology of 
some autoimmune diseases,[12] further studies on microwebs 
should address their correlations with human disease or guide 
further efforts to design non-DNA based artificial NETs for clin-
ical tests.
Experimental Section
Preparation of Microwebs: Microwebs was prepared by spontaneous 
polymerization of methylated lambda phage DNA in the presence of 
histone. Calf thymus histone (Sigma, H9250) and methylated lambda 
phage DNA (Sigma, D3779) were separately dissolved and diluted in 
HBSS. The DNA (100–400 µg mL−1) and histone concentration were 
measured from Nanodrop 2000c. To prepare microwebs, the DNA 
solution (100 µL, 100–400 µg mL−1) was mixed with histone (100 µL) 
solutions using an ultrasonic homogenizer (Qsonica Q125 sonicator, 
intensity set 20%) for 15 s. Depending on the weight fraction of histone 
in microwebs, the concentration of histone was varied from 33 to 
400 µg mL−1. As a comparison, NETs isolated from neutrophils (see the 
experimental details in the Supporting Information) were dispersed into 
HBSS by sonication under the same conditions (intensity set 20%, last 
for 15 s).
Characterization: The zeta potentials of microwebs (DNA: 50 µg mL−1) 
were measured using a zetasizer (Malvern) at 37 °C. Their size 
distribution was measured using Wyatt DynaPro NanoStar Dynamic 
Light Scattering. NETs formed from neutrophils were dispersed into 
HBSS by sonication for 15 s before DLS measurement. Morphology 
of microwebs (with and without E. coli) were imaged using scanning 
electron microscopy (Hitachi SU8230, Uacc = 1 kV, I = 15 mA). The SEM 
samples were fixed by 4% paraformaldehyde, washed with deionized 
water, and sequentially dehydrated in 25, 50, 75, 95, and 100 vol% 
ethanol. Subsequently, samples were immersed in hexamethyldisilane 
and vacuumed overnight. Dried samples were sputter-coated with gold 
nanoparticles (SPI-Module 60s, 18 mA).
Degradation: Suspension of microwebs (100 µL, preheated to 
37 °C) was prestained with SYTOX green (1 × 10−6 m) and mixed with 
DNase solutions (bovine pancreas DNase I, Sigma 11284932001, 
diluted in HBSS) at equal volumes. The final concentration of DNase 
was 1, 10, 100, and 500 µg mL−1. Degradation of the microwebs was 
monitored in a Synergy Neo2 Multi-mode microplate reader (BioTek, 
Ex/Em = 488/523 nm) at 37 °C for 4 h.
Bacterial Media and Growth Conditions: E. coli UTI89 was streaked 
on a tryptic soy agar (TSA, Sigma 22091) plate and incubated at 37 °C 
Adv. Mater. 2019, 31, 1807436
Figure 4. Microwebs can work cooperatively with antibiotics against E. coli. CFU counting of E. coli (inoculum = 105 cells) after culture in a 100 µL 
HBSS containing 100 µg mL−1 microwebs (ωhis = 50%) plus antibiotics: a) colistin and b) amoxicillin for 1 h at 37 °C. Comparisons on the growth 
curves of E. coli (inoculum = 106 cells) cultured in a mixture solution of 100 µL TSB, 100 µL HBSS, microwebs, and antibiotics: c) with colistin, without 
microwebs; d) with colistin, with 50 µg mL−1 microwebs; e) with amoxicillin, without microwebs; and f) with amoxicillin, with 50 µg mL−1 microwebs. 
**P < 0.01; ***P < 0.001.
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overnight. One colony was scratched from TSA plate and suspended in 
1 mL tryptic soy broth (Sigma 22092) with 1% glucose, until the optical 
density at 600 nm (OD600) of the cultures reached 0.3–0.6. The E. coli 
suspension was diluted to OD600 = 0.01.
Bacteria-Trapping Assay: Suspension of microwebs (100 µL, 
containing 50 µg mL−1 DNA) was pipetted into 96-well microplates and 
centrifuged (4000 rpm, 10 min). E. coli culture (100 µL, OD600 = 0.01 in 
HBSS) prestained with SYTO 9 was added on top of the microwebs and 
centrifugated (4000 rpm, 10 min). Motion of E. coli was continuously 
monitored for 1 h using fluorescence microscopy (Nikon Eclipse 80i). 
The percentage of trapped E. coli is expressed as the ratio of nonmotile 
E. coli to the total number of bacteria. After 1 h of incubation at 37 °C, 
the planktonic E. coli in the supernatant was collected, serial diluted 
by tenfold using HBSS, and transferred to agar plates. After overnight 
incubation, the E. coli colonies were numerated.
Cell Viability Assay: Suspension of E. coli cells (100 µL, OD600 = 0.01 
in HBSS) was allocated into a 96-well microplate and centrifugated 
(4000 rpm, 10 min). Afterward, suspension of microwebs (100 µL) was 
slowly injected on top of cells and centrifuged (4000 rpm, 10 min). After 
1 h of incubation (37 °C), the microwebs on top of E. coli were removed by 
repeated pipette washing (HBSS) for 3–5 times. The E. coli cells attached 
to the microplate substrate were stained (0.5 vol% 3.34 × 10−3 m SYTO 9 
and 0.5 vol% 20 × 10−3 m propidium iodide, 15 min, Thermofisher L7012), 
washed with deionized water, and imaged via fluorescence microscopy 
(Nikon Eclipse 80i, Nikon A1Rsi).
Bacteria Proliferation Assay: Proliferation of E. coli was measured from 
OD600 of the bacteria culture suspension using a plate reader (Biotek). 
100 µL TSB containing 106E. coli cells were mixed with 100 µL microwebs 
(in HBSS, whis = 50%) at different concentrations of 0, 25, 50, and 
100 µg mL−1. E. coli were cultured at 37 °C for 7 h and their corresponding 
OD600 values were measured (OD600 of microweb suspension without 
E. coli was subtracted as background). Three independent bacteria 
colonies were used. Data are presented as mean values ± S.D.
Quantitative Culture: 105 E. coli cells (in 10 µL HBSS) were mixed with 
suspension of microwebs (100 µL, 100 µg mL−1 in HBSS) and incubated for 
1 h (37 °C). Next, 10 µL mixture was extracted from each sample and diluted 
with HBSS at a volumetric ratio of 1:1000. Subsequently, 10 µL of the diluted 
solution samples was spotted onto the agar plate; this liquid transfer was 
repeated 6 times for each sample. The spotted agar plate was incubated at 
37 °C for 12 h. The numbers of CFUs were then enumerated. Four different 
E. coli colonies were tested for CFU enumeration, and unpaired Student’s 
t-test was employed to quantify the statistical significance using P-values.
Antibiotic Tests: Four antibiotics were separately dissolved in deionized 
water as stock solutions (colistin, Sigma, PHR1605 20 µg mL−1; 
amoxicillin, Sigma, PHR1127, 400 µg mL−1; trimethoprim, Sigma, 
PHR1056 200 µg mL−1; nitrofurantoin, Sigma, PHR1191, 1 mg mL−1). 
These antibiotics were diluted in either suspension of microwebs or 
HBSS to desired concentrations. For quantitative culture, 105 cells were 
suspended in a mixture of 100 µL HBSS (with and without 100 µg mL−1 
microwebs) and 100 µL antibiotic solution. For growth curves, 106 cells 
were seeded in a mixture of 100 µL TSB, 100 µl HBSS (with and without 
100 µg mL−1 microwebs microwebs) and antibiotics. Quantitative 
culture and growth curves were performed following the same protocols 
as above. The MIC was determined by standard broth microdilution. 
106 cells mL−1 were inoculated into increasing concentrations of 
antibiotic  ± microwebs. After 16-h incubation at 37 °C, the MIC was 
identified as the lowest concentration with no visible bacterial growth.
Supporting Information
Supporting Information is available from the Wiley Online Library or 
from the author.
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